Close Menu

One Step Down

IBM has developed lab-on-a-chip diagnostic tool, reports Technology Review. In the prototype, a small amount of blood flows through the chips' capillaries — as small as 30 micrometers. There, antibodies bind to disease markers in the blood, to diagnose a disease in 15 minutes, according to Emmanuel Delamarche who worked on the device at IBM Zurich Research Laboratory. Those compounds are then detected by another set of antibodies and measured with a fluoresce reader.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.